My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Eli Lilly (NY:LLY)

1,076.98 +5.34 (+0.50%)

Official Closing Price Updated: 5:00 PM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks ↗

August 23, 2025

Incorporating top stocks from a variety of sectors can be an effective way to balance out an investment portfolio.

Via The Motley Fool

Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks? ↗

August 23, 2025

Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF.

Via The Motley Fool

Topics ETFs Stocks

This Is What Whales Are Betting On Eli Lilly ↗

August 20, 2025

Via Benzinga

This Drugmaker Stock Slumped 36% In Tuesday’s Premarket Session: Here’s Why ↗

August 19, 2025

Via Stocktwits

Warren Buffett Makes a Big Buy ↗

August 22, 2025

Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all.

Via The Motley Fool

Topics Economy

Options Corner: Embattled Drug Maker Novo Nordisk May Offer Speculators A Quick Profit-Scalping Opportunity ↗

August 22, 2025

Although Novo Nordisk has been struggling for over a year, the relative discount may attract bullish speculators to NVO stock.

Via Benzinga

$1000 Invested In Eli Lilly 15 Years Ago Would Be Worth This Much Today ↗

August 22, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 22, 2025

Via Benzinga

Here's Why Shares in Viking Therapeutics Crashed This Week ↗

August 22, 2025

The phase 2 trial results for its key drug didn't pan out quite as planned.

Via The Motley Fool

Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried? ↗

August 22, 2025

There are some reasons to be worried; there are also reasons to be optimistic.

Via The Motley Fool

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. ↗

August 22, 2025

The tariffs will impact products imported from Europe, the Trump administration said late Thursday.

Via Investor's Business Daily

Topics ETFs Government Intellectual Property

J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs ↗

August 22, 2025

Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs...

Via Benzinga

Topics Government World Trade

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 21, 2025

Via Benzinga

Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets ↗

August 21, 2025

The race inside the weight loss industry is ramping up, leaving investors with three names to choose from in how they want to play this theme.

Via MarketBeat

Is Beaten-Down Viking Therapeutics Stock a Buy on the Dip? ↗

August 21, 2025

A disappointing result for its oral obesity candidate hammered the stock price.

Via The Motley Fool

Here's Why Viking Therapeutics Bounced Back Today ↗

August 20, 2025

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data were disappointing.

Via The Motley Fool

Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny

August 20, 2025

The financial markets are a dynamic arena where fortunes can shift rapidly, and the past week has seen two prominent companies, Palantir Technologies Inc. (NYSE: PLTR) and Viking Therapeutics (NASDAQ:...

Via MarketMinute

Topics Artificial Intelligence

Novo Nordisk Freezes Hiring As Wegovy Faces Copycats ↗

August 20, 2025

Novo Nordisk may pursue layoffs as its new CEO focuses on efficiency while facing intensifying obesity drug competition.

Via Benzinga

Topics Workforce

Is the Vanguard Dividend Appreciation ETF a Buy Now? ↗

August 20, 2025

This stalwart ETF offers a little bit of everything and could outperform the S&P 500 if the Magnificent Seven stocks tumble.

Via The Motley Fool

Topics ETFs Stocks

One of the Best Stocks to Buy Now? ↗

August 20, 2025

I ranked Eli Lilly as one of the best stocks to buy starting in 2025.

Via The Motley Fool

What's Going on With Eli Lilly Stock? ↗

August 20, 2025

The pharma company is gaining investor attention due to increasingly popular products.

Via The Motley Fool

Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year ↗

August 20, 2025

Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark.

Via Stocktwits

Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug? ↗

August 20, 2025

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it's inferior.

Via Benzinga

Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns

August 19, 2025

San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...

Via MarketMinute

Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme' ↗

August 19, 2025

Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off is excessive.

Via Benzinga

Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks ↗

August 19, 2025

Insiders are buying stocks like LLY, TFX, and CALC. The question is whether they are also a good buy for investors, and not all of them are.

Via MarketBeat

Why Novo Nordisk Stock Popped Today ↗

August 19, 2025

For a cheap GLP-1 weight loss stock like Novo Nordisk, almost any news can help the stock pop.

Via The Motley Fool

Why Viking Therapeutics Stock Crashed Today ↗

August 19, 2025

Viking's new GLP-1 weight loss pill is pretty great -- but is it enough to turn the company profitable?

Via The Motley Fool

Eli Lilly Stock Investors Need to See This ↗

August 19, 2025

Competition among the makers of weight loss treatments is intensifying.

Via The Motley Fool

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks ↗

August 19, 2025

Viking Therapeutics reported positive Phase 2 results for VK2735, showing significant weight loss and safety in obesity patients versus placebo.

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.